Hypofractionation for radiotherapy of prostate cancer using a low alfa/beta ratio –– possible reasons for concerns? An example of five dimensional radiotherapy

By Lennernääs Bo   Nilsson Sten   Levitt Seymour  

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 111-115

Informa Healthcare

Access to resources Recommend Favorite

State-of-the-art radiotherapy in the management of clinically localized prostate carcinoma

By Bermudez R Scott   Izaguirre Alejandra   Roach Mack  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 103-111

Future Medicine

Access to resources Recommend Favorite

State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer

By Heijmink Stijn W. T. P. J.   Füütterer Jurgen J.   Strum Stephen S.   Oyen Wim J. G.   Frauscher Ferdinand   Witjes J. Alfred   Barentsz Jelle O.  

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 25-38

Informa Healthcare

Access to resources Recommend Favorite

State-of-the-Art and Future Directions in Multilevel Interventions Across the Cancer Control Continuum

By Stange Kurt C.   Breslau Erica S.   Dietrich Allen J.   Glasgow Russell E.  

Journal of the National Cancer Institute Monographs, Vol. 2012, Iss. 44, 2012-01 ,pp. : 20-31

Oxford University Press

Access to resources Recommend Favorite

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

By Schick Ulrike   Jorcano Sandra   Nouet Philippe   Rouzaud Michel   Vees Hansjoerg   Zilli Thomas   Ratib Osman   Weber Damien C.   Miralbell Raymond  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1622-1628

Informa Healthcare

Access to resources Recommend Favorite